Dr. Evidence is a software company based in the United States, founded in 2004, with a workforce of 51 to 200 employees and reported annual revenue of approximately $30 million. The company specializes in providing document intelligence solutions, particularly in the pharmaceutical sector. One of its key offerings is the Label Intelligence solution, which is designed to enhance the efficiency of label research and competitive analysis for pharmaceutical companies. A recent case study highlighted the effectiveness of Label Intelligence, where a top ten pharmaceutical company utilized the software for rapid precedent research, competitive label comparisons, and real-time monitoring of drug labels. The solution was rated 4.5 out of 5 for its ability to meet business objectives, with all participants in the study acknowledging its advantages over other labeling software. Users reported significant time savings and improved accuracy in finding relevant information, underscoring the platform's advanced search capabilities. Dr. Evidence continues to focus on streamlining regulatory affairs and pharmacovigilance through its innovative software solutions.